AXS Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Sell
141
-40
-22% -$40.6K 0.05% 130
2025
Q4
$195K Sell
181
-53
-23% -$50.7K 0.07% 133
2025
Q3
$179K Buy
+234
New +$174K 0.06% 133
2025
Q2
Sell
-1,664
Closed -$1.37M 187
2025
Q1
$1.37M Sell
1,664
-359
-18% -$299K 0.38% 104
2024
Q4
$1.56M Buy
2,023
+384
+23% +$318K 0.43% 71
2024
Q3
$1.45M Sell
1,639
-132
-7% -$119K 0.39% 110
2024
Q2
$1.6M Sell
1,771
-229
-11% -$183K 0.45% 84
2024
Q1
$1.56M Sell
2,000
-475
-19% -$338K 0.37% 84
2023
Q4
$1.44M Sell
2,475
-129
-5% -$75.3K 0.35% 89
2023
Q3
$1.4M Sell
2,604
-617
-19% -$318K 0.36% 75
2023
Q2
$1.51M Sell
3,221
-1,019
-24% -$427K 0.4% 66
2023
Q1
$1.46M Buy
4,240
+676
+19% +$228K 0.48% 49
2022
Q4
$1.3M Sell
3,564
-674
-16% -$239K 0.47% 61
2022
Q3
$1.37M Buy
4,238
+226
+6% +$71.6K 0.53% 43
2022
Q2
$1.3M Buy
4,012
+2,453
+157% +$736K 0.46% 54
2022
Q1
$446K Sell
1,559
-2,561
-62% -$659K 0.18% 91
2021
Q4
$1.14M Buy
+4,120
New +$1.04M 0.27% 75
2021
Q3
Sell
-3,427
Closed -$787K 167
2021
Q2
$787K Buy
3,427
+214
+7% +$43K 0.24% 90
2021
Q1
$600K Buy
+3,213
New +$628K 0.21% 97

Other funds holding LLY

AXS Investments's LLY Position: Q1 2026 in Review

AXS Investments reduced its Eli Lilly (LLY) stake by 22% in Q1 2026, selling an estimated $40.6K and leaving 141 shares worth $130K. The position accounts for 0.05% of the portfolio, ranked #130.

AXS Investments first reported a position in LLY in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.6M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • AXS Investments held 141 shares of Eli Lilly worth $130K as of Q1 2026.
  • AXS Investments sold 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
  • Eli Lilly made up 0.05% of AXS Investments's portfolio in Q1 2026, its #130 holding.
  • AXS Investments first reported a position in Eli Lilly in Q1 2021 and has held it in 19 quarters since.
  • AXS Investments's Eli Lilly position peaked at $1.6M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.